Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Assets Average (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Assets Average for 7 consecutive years, with $101.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average fell 36.55% to $101.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $101.2 million, a 36.55% decrease, with the full-year FY2024 number at $148.1 million, down 25.58% from a year prior.
  • Assets Average was $101.2 million for Q3 2025 at Precision Biosciences, down from $116.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $284.4 million in Q3 2022 to a low of $101.2 million in Q3 2025.
  • A 5-year average of $190.8 million and a median of $193.1 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: soared 37.59% in 2021, then crashed 39.17% in 2023.
  • Precision Biosciences' Assets Average stood at $219.3 million in 2021, then grew by 16.23% to $255.0 million in 2022, then plummeted by 36.43% to $162.1 million in 2023, then decreased by 10.64% to $144.8 million in 2024, then tumbled by 30.11% to $101.2 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Assets Average are $101.2 million (Q3 2025), $116.7 million (Q2 2025), and $130.4 million (Q1 2025).